RXi Pharmaceuticals Corp. | Key People and Executives
Geert Cauwenbergh
President, CEO, CFO & Director
Robert J. Bitterman
Chairman
Jonathan Freeman
Independent Director
Curtis A. Lockshin
Independent Director
H. Paul Dorman
Independent Director
Geert Cauwenbergh
President, CEO, CFO & Director
Caitlin Kontulis
Secretary & Finance Director
Pamela A. Pavco
Scientific Advisory Board Member
Gerrit Dispersyn
Chief Development Officer
James Cardia
Director-Business Development
Tamara McGrillen
Investor Relations Contact
Robert J. Bitterman
Chairman
Jonathan E. Freeman
Independent Director
Curtis A. Lockshin
Independent Director
H. Paul Dorman
Independent Director
| Address |
257 Simarano Drive
Marlborough Massachusetts 01752
United States
|
|
Employees
|
- |
| Website |
http://www.rxipharma.com |
| Updated |
09/14/2018 |
| RXi Pharmaceuticals Corp. is a biotechnology company, which engages in developing therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA. |
